Large vessel vasculitis;Vaskulitiden der großen Gefäße

Internist

Volumn 50, Issue 8, 2009, Pages 958-963

  Caspary, L ^a   Schellong, S ^b  

^a Angiologische Praxis Luisenstrasse und Klinikum Oststadt Heidehaus   (Germany)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Giant cell arteritis; Large vessel vasculitis; Takayasu arteritis; Vascular imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOTREXATE; PREDNISOLONE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ANEURYSM; AORTA ARCH SYNDROME; ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; GIANT CELL ARTERITIS; GREAT BLOOD VESSEL; HUMAN; TEMPORAL ARTERITIS; VASCULITIS; VASODILATATION; ANGIOGRAPHY; ARTERITIS; METHODOLOGY; REVIEW;

ANGIOGRAPHY; ANTI-INFLAMMATORY AGENTS; ARTERITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 68549125079     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-009-2363-5     Document Type: Article

References (27)

1. Andrews J, Mason JC (2007) Takayasu's arteritis recent advances in imaging offer promise. J Rheumatol 46:6-15
2. Arend WP, Michel BA, Block DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129-1134
3. Bird HA, Esselincks W, Dixon AS et al. (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434-439
4. Blockmans D, Bley T, Schmidt W (2009) Imaging for large-vessel vasculitis. Curr Opin Rheumatol 21 : 19-28
5. Bongartz T, Matteson EL (2006) Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 18:10-17
6. Brack A, Martinez-Taboada V, Stanson A et al. (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 42:311-317
7. Dasgupta B, Salvarani C, Schirmer M et al. (2008) Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol 35:270-277
8. Evans JM, O'Fallon WM, Hunder GG (1995) Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 122:502-50
9. Hoffmann GS, Leavitt RY, Kerr GS et al. (1994) Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 36:568-582
10. Hoffman GS, Cid MC, Rendt-Zagar KE et al. (2007) Infliximab for maintenance of glucocorticosteroidinduced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146:621-630
11. Hunder GG, Bloch DA, Michel BA et al. (1990)The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122-1128
12. Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides, Proposal of an international consensus conference. Arthritis Rheum 36:186-192
13. Kerr GS, Hallahan CW, Giordano J et al. (1994) Takayasu arteritis. Ann Intern Med 120:919-929
14. Mahr AD, Jover JA, Spiera RF et al. (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56:2789-2797
15. Mazlumzadeh M, Hunder GG, Easley KA et al. (2006) Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 54:3310-3318
16. Molloy ES, Langford CA, Clark TM et al. (2008) Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 67:1567-1569
17. Moriwaki R, Noda M, Yajima M (1997) Clinical manifestations of Takayasu arteritis in India and Japan - new classification of angiographic findings. Angiology 48:369-379
18. Mukhtyar C, Guillevin L, Cid MC (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68:318-323
19. Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161-1168
20. Pryshchep O, Ma-Krupa W, Younge BR et al. (2008) Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 118:1276-1284
21. Rodrfguez-Pla A, Rosselló-Urgell J, Bosch-Gil JA et al. (2007) Proposal to decrease the number of negative temporal artery biopsies. Scand J Rheumatol 36:111-118
22. Salvarani C, Cantini F, Hunder GG (2008) Polymyalgia rheumatica and giant-cell arteritis. Lancet 372: 234-245
23. Schmidt WA, Kraft HE, Vorpahl K et al. (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337:1336-1342
24. Schmidt WA, Nerenheim A, Seipelt E et al. (2002) Diagnosis of early Takayasu arteritis by colour Doppler ultrasonography. Rheumatology 41:496-502
25. Tatò F, Hoffmann U (2008) Giant cell arteritis: a systemic vascular disease. Vascular Med 13:127-140
26. Weyand CM, Goronzy JJ (2003) Mechanisms of disease: Medium- and large-vessel vasculitis. N Engl J Med 349:160-169
27. Zehr KJ, Mathur A, OrszulakTA et al. (2005) Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg 79: 1512-1517